The news mentions that this exemption rule applies when a manufacturer producing a new drug patented under the Indian Patent Act, 1970 and is not produced elsewhere, if developed through indigenous research. The rule includes use of a new process developed through indigenous research”
It seems Wockhardt’s R&D efforts have started paying off! (It spends one of highest R&D expense as % to sales for Indian pharma company)
| Subscribe To Our Free Newsletter |
